AIMS Monitoring Frequency for Second-Generation Antipsychotics
Administer AIMS at baseline before starting the antipsychotic, then weekly for 6 weeks, at 3 months, and annually thereafter.
Recommended Monitoring Schedule
The most recent international guideline for antipsychotic treatment provides a clear framework for monitoring that should be applied to AIMS administration 1. While the guideline specifically details metabolic monitoring parameters, the same temporal framework applies to movement disorder screening:
- Baseline: Before initiating antipsychotic treatment
- Weekly for 6 weeks: During the initial treatment period
- 3 months: After starting or switching antipsychotics
- Annually: For ongoing maintenance treatment
This schedule mirrors the metabolic monitoring protocol outlined in the 2025 INTEGRATE guidelines 1, which represents the most current expert consensus on antipsychotic management.
Clinical Rationale
The weekly monitoring during the first 6 weeks captures the period of highest risk for acute extrapyramidal symptoms and early-onset movement disorders. The 3-month checkpoint allows detection of subacute movement problems that may emerge as the medication reaches steady state. Annual monitoring thereafter provides ongoing surveillance for tardive dyskinesia, which can develop at any point during antipsychotic treatment.
Important Caveats
More frequent monitoring is warranted when:
- Switching between antipsychotics (restart the 6-week weekly schedule)
- Dose adjustments are made
- New movement symptoms are reported or observed
- The patient is on high-risk antipsychotics (though second-generation agents generally carry lower risk than first-generation)
The AIMS examination should be integrated into routine clinical care rather than performed as an isolated screening test 2. This approach facilitates ongoing informed consent discussions about tardive dyskinesia risk and improves early detection 3.
The AIMS is not specific for tardive dyskinesia alone 2—it detects various abnormal involuntary movements. Any positive findings require clinical interpretation to determine the underlying cause and appropriate management.